New bone-in technique tests therapies for breast cancer metastasis

New bone-in technique tests therapies for breast cancer metastasis
Dr. Xiang Zhang, associate professor of molecular and cellular biology and the Lester and Sue Smith Breast Center, and McNair Scholar at Baylor College of Medicine. Credit: Baylor College of Medicine

A new laboratory technique developed by researchers at Baylor College of Medicine and other institutions can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone. The study appears in Nature Communications.

"For a number of , the problem is metastasis—the dissemination of breast tumor cells to other organs—after the primary tumor has been eliminated," said corresponding author Dr. Xiang Zhang, associate professor of molecular and cellular biology and the Lester and Sue Smith Breast Center at Baylor. "Metastases, however, tend to respond differently than the primary tumor to the treatment in part due to residing in a different organ with a different microenvironment."

Until now, there has not been an effective experimental platform to study metastatic tumors in their new microenvironment.

"We have created an experimental system in which we can mimic the interactions between and bone cells, as bone is the place where breast cancer, and many other cancers too, disseminates most frequently," said Zhang, who also is a McNair Scholar at Baylor. "We have developed a system that allows us to test many different drug responses simultaneously to discover the therapy that can selectively act on metastatic cancer cells and minimize the effect on the bone."

Bone-in culture array

To mimic the interactions between cells and in a living system in the lab, Zhang and his colleagues developed a model, called bone-in culture array, by fragmenting mouse bones that already contain .

The scientists determined that the bone-in culture maintains the microenvironmental characteristics of bone metastasis in living animal models, and the cancer cells maintain the gene expression profile, the growth pattern and their response to therapies.

Using the bone-in model, the researchers determined that the drug danusertib preferentially inhibits bone metastasis. They also found that other drugs stimulate the growth of slow-growing cancer cells in the bone.

In addition to determining the effect of drugs in the growth of metastasis in bone, the bone-in culture can be used to investigate mechanisms involved in bone colonization by cancer cells.

Implications for cancer treatment

"We think that this new system has the potential to be applied not only to but to other cancers that also metastasize to the bone," Zhang said. "This technique can be scaled up to larger sample sizes, which would help accelerate the process of discovering metastatic cancer treatments. We have already found a few interesting drugs. We will keep looking for more and focus on those that are most promising."

In the future, the scientists expect to develop this platform into a standardized system that can be used in the clinic to find specific drugs that can better treat metastatic .

More information: Hai Wang et al, Bone-in-culture array as a platform to model early-stage bone metastases and discover anti-metastasis therapies, Nature Communications (2017). DOI: 10.1038/ncomms15045

Journal information: Nature Communications
Citation: New bone-in technique tests therapies for breast cancer metastasis (2017, April 21) retrieved 19 March 2024 from https://medicalxpress.com/news/2017-04-bone-in-technique-therapies-breast-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Tracking breast cancer cells on the move

18 shares

Feedback to editors